July 3, 2023

Sue Peschin – FDA, CMS, and Alzheimer’s Drugs: What Do American Voters Want?

Sue Peschin – FDA, CMS, and Alzheimer’s Drugs: What Do American Voters Want?

About This Episode

Should Alzheimer’s drugs be treated like all other drugs when it comes to Medicare coverage? The Alliance for Aging Research CEO Sue Peschin and BrainStorm host Meryl Comer dive into polling data that reveals most American voters, regardless of party, disagree with CMS’s policy that will limit access. Their conversation sheds light on how the coverage decision, if it stands, will create not only greater disparities, but also have wide-ranging implications on coverage for other disease-modifying therapies. 

This episode is sponsored by Eisai.

Support the show

BrainStorm Feed

86

Muffy Walker, Author of "Memory Weavers"

In this episode of BrainStorm by UsAgainstAlzheimer's Muffy Walker, a psychiatric nurse, founder of the International Bipolar Foundation, and autho

LISTEN NOW
85

Trump’s Policies and the Effect on Alzheimer's with George Vradenburg and Russ Paulsen

In this episode of the "BrainStorm" by UsAgainstAlzheimer's, George Vradenburg, Co-founder and Chairman of UsAgainstAlzheimer's, and Russ Paulsen,

LISTEN NOW
84

Greg O'Brien – Advocating for Scientific Research for Alzheimer’s

Journalist and author Greg O'Brien, diagnosed with early-onset Alzheimer's over a decade ago, shares with BrainStorm host Meryl his determination t

LISTEN NOW